These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 21346758
1. Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanil. Kharasch ED, Vangveravong S, Buck N, London A, Kim T, Blood J, Mach RH. Clin Pharmacol Ther; 2011 Apr; 89(4):562-70. PubMed ID: 21346758 [Abstract] [Full Text] [Related]
3. Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction. Kharasch ED, Francis A, London A, Frey K, Kim T, Blood J. Clin Pharmacol Ther; 2011 Jul; 90(1):100-8. PubMed ID: 21562488 [Abstract] [Full Text] [Related]
4. Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam. Chaobal HN, Kharasch ED. Clin Pharmacol Ther; 2005 Nov; 78(5):529-39. PubMed ID: 16321619 [Abstract] [Full Text] [Related]
5. Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimally invasive and noninvasive probes for hepatic and first-pass CYP3A activity. Kharasch ED, Walker A, Hoffer C, Sheffels P. J Clin Pharmacol; 2005 Oct; 45(10):1187-97. PubMed ID: 16172184 [Abstract] [Full Text] [Related]
8. Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies. Kharasch ED, Whittington D, Hoffer C, Krudys K, Craig K, Vicini P, Sheffels P, Lalovic B. Clin Pharmacokinet; 2005 Oct; 44(7):731-51. PubMed ID: 15966756 [Abstract] [Full Text] [Related]
10. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone. Kharasch ED, Hoffer C, Whittington D, Sheffels P. Clin Pharmacol Ther; 2004 Sep; 76(3):250-69. PubMed ID: 15371986 [Abstract] [Full Text] [Related]
11. Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam. Kharasch ED, Walker A, Isoherranen N, Hoffer C, Sheffels P, Thummel K, Whittington D, Ensign D. Clin Pharmacol Ther; 2007 Oct; 82(4):410-26. PubMed ID: 17554244 [Abstract] [Full Text] [Related]
12. Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A). Kharasch ED, Bedynek PS, Hoffer C, Walker A, Whittington D. Anesthesiology; 2012 Feb; 116(2):432-47. PubMed ID: 22273859 [Abstract] [Full Text] [Related]